Prevalence of Temporomandibular Joint Disorders Among Egyptian University Undergraduate Students

August 2, 2021 updated by: Maram Ahmed Taema, Cairo University
This study will take place in Egypt. Undergraduate students from different faculties of the Egyptian Universities will participate. The study began in December 2020.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Matching criteria and allocation ratio: The planned study a single arm cross sectional study, in which the prevalence of students of TMD will be reported. The association between TMD and other variables will be also studied. Therefore, no matching criteria or allocation ratio are required.

Variables It has been shown from literature that many variables are associated with TMD. It was therefore, decided to study the correlation between these variables with TMD among Egyptian population via a regression model once the assumption for regression analysis are satisfied. Binary variables are analyzed through logistic regression, while continuous data through a multivariable regression analysis. If one of the assumptions for regression analysis is violated, a subgroup analysis for each variable will be considered.

These Variables include gender, age, psychological stress, oral habits, parafunctional activities as gum chewing, previous dental treatments , previous trauma to jaws.

Data sources and management Data sources, the answered questionnaires and subsequent spread sheets will only be shared by the team members.

Addressing potential sources of bias Selection bias: an email will be sent to all the students through their university email addresses. Due to the COVID-19 situation only convenient sampling could be used. whenever possible printed questionnaires are handed to the students.

Quantitative variables: Handling of quantitative variables in the analyses None of the data is a continuous variable. All exposure factors are binary or categorical data. Therefore, no plans are set for simplifying continuous data or converting them into binary ones.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All undergraduate students in Egyptian Universities

Description

Inclusion Criteria:

  1. -Undergraduate students in Egyptian universities
  2. Age ranges from 18-45 years
  3. Males and females

Exclusion criteria

  1. school students
  2. students not living in egypt

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Undergraduate students
prevalence of TMD among undergraduate students
Fonesca questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence of TMDs in Egyptian university students
Time Frame: 3 months
Fonseca Questionnaire
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ramsis Magdy, BDS, Cairo university
  • Study Chair: Azza Hussein, PhD, Cairo university
  • Study Director: Maram Taema, Master, Cairo university
  • Principal Investigator: Amr Nagib, PhD, Cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2020

Primary Completion (ANTICIPATED)

August 1, 2022

Study Completion (ANTICIPATED)

November 1, 2022

Study Registration Dates

First Submitted

November 1, 2020

First Submitted That Met QC Criteria

November 1, 2020

First Posted (ACTUAL)

November 6, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 4, 2021

Last Update Submitted That Met QC Criteria

August 2, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bruxism

Clinical Trials on some risk factors that might be correlated with TMD

Subscribe